About Primary hypomagnesemia with hypercalciuria and nephrocalcinosis
Primary hypomagnesemia with hypercalciuria and nephrocalcinosis is a rare disease catalogued by Orphanet (ORPHA:306516). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Primary hypomagnesemia with hypercalciuria and nephrocalcinosis trials.
Search ClinicalTrials.gov for "Primary hypomagnesemia with hypercalciuria and nephrocalcinosis" or Orphanet code ORPHA:306516 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Primary hypomagnesemia with hypercalciuria and nephrocalcinosis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Primary hypomagnesemia with hypercalciuria and nephrocalcinosis. Updated daily.